Bespoke Medical Innovations are Distributors of:
Supplier of orthopaedic and sports medicine implants and instruments.
- Femoral Implants
- Hip Implants
Finance and Operations Director
Brendon is responsible for the company’s finance and operational deliverables. Brendon is a certified practising chartered Accountant with significant experience in a number of industries in both national and multi-national companies. These include IT&T (Alcatel-Lucent), FMCG (H.J. Heinz), Manufacturing (HPM Legrand), Training and Conferencing, Supply Chain and Chartered Accountancy.
Brendon thrives on developing and implementing business strategy and building teams to support growth and profitability in companies via technical support and a 'can-do' attitude.
Over recent years Brendon was integral to the selling of three highly successful companies.
Director of Strategy & Innovation
Phil is responsible for the company’s evolution of intellectual property, innovation, and Research & Development. He has proven-ability creating capable teams, fostering positive work culture, and applying innovative-thinking leading to commercial success.
Phil has a design engineering and executive background with over 26 years of medical device industry experience in both Class II and Class III devices including patient masks, sleep apnea/respiratory devices, and cardiac electrophysiology catheters.
Phil was Chief of Technology with ResMed, a multi-national Sleep and Respiratory medical device company, from its start-up phase for almost 24 years, while operating at chief engineer level and subject matter expert for patient mask interfaces, and named an inventor in over 1,400 medical device patent cases including 300+ patents granted in the USA.
Chief Technology Officer
John’s focus is on the technical and scientific issues associated with each custom product Bespoke is involved in commercialising.
John is a mechatronicware entrepreneur with three degrees in science and engineering and has been involved with numerous technologies in the mechanical, electronic and software fields.
For his Masters thesis John developed a 3D mouse called the Spaceball, which his employer commercialised following additional investment from a private Australian investor. Spaceball’s company, Spacetec IMC Corporation, went public on NASDAQ in 1995 raising US$16M before merging with Labtec Inc. in 1999.
John returned to Australia in 1999 and became the Chief Technology Officer for a Brisbane based start-up that commercialised several inventions in the medical, sports, building and computer industries. He then re-developed a new 3D mouse and founded Spatial Freedom Pty Ltd in 2005 to commercialise this technology to expand the 3D mouse into new markets.
In recent years John has provided technical contracting to various companies to resolve mechanical, electronic and/or software issues with their products. In 2013 he was contracted by Bionic Vision Australia (BVA) to manage their Externals division that was responsible for the non-implanted electronics.
Chris has specific focus on continued development of the ApneaSeal technology, and automation and refinement of the production processes involved. Chris has two degrees in engineering, and his work has been published in a number of peer reviewed journals. Chris enjoys working in the medical device industry as it allows him to combine knowledge from different engineering disciplines in order to improve a person’s quality of life.
Prior to joining Bespoke Medical Innovations, Chris spent 7 years working in bionic vision research at the University of New South Wales. He led the team focused on developing neural interfaces, and solving problems related to the miniaturisation of the implantable components of the system.
Bespoke Medical Innovation’s Advisory Board provides advice and insight to the senior management team relating to strategy, finance, operations and emerging technology opportunities.
Medical Advisory Board
Bespoke Medical Innovation’s Medical Advisory Board consists of independent expert physicians who provide technical advice to the Board relating to the clinical efficacy and effectiveness of any medical technologies being considered.
Medical Advisory Chair
Dr Peter Hannaford M.B., B.S., F.A.S.M.F., F.A.C.S.P., F.R.A.C.S., F.A.Orth.A.